UNSPSC 51341506: Fosamprenavir sodium

This classification denotes an enzyme inhibitor with the molecular formula C25H34N3O9PS.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XSG28FSA0W, chemically known as carbamic acid, ((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, c-((3s)-tetrahydro-3-furanyl) ester, disodium salt but more generally known as fosamprenavir sodium, which bears US NIH Compound Identifier 131537.

Most nations, for tariff and trade purposes, schedule fosamprenavir sodium under HS 29350090 and SITC 51580. As of Q4 2014, FOSAMPRENAVIR SODIUM remains US FDA's Preferred Term for this commodity. Fosamprenavir sodium bears US NLM identifiers UMLS ID C1366241 and NCI Concept Code C72786. SMILES: CC(C)CN(C[C@H]([C@H](CC1CCCCC1)NC(=O)O[C@H]2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3CCC(CC3)N.[NA+].[NA+].

UNSPSC 51341506 Fosamprenavir sodium is a Commodity code for a specific antiretroviral pharmaceutical product; however, recent state and local procurement activity tagged under this code shows little alignment with the nominal commodity scope. The Illinois Department of Public Health and Seminole County, Florida have posted opportunities classified under this code, but neither procurement involves fosamprenavir sodium or antiretroviral medications. Instead, the Illinois solicitation addresses broad-spectrum antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) through a piggyback contract with MMCAP Infuse, while the Seminole County opportunity targets naloxone and drug deactivation systems for community health support. This classification mismatch suggests the code may be applied inconsistently by issuing bodies or serves as a catch-all taxonomy entry for certain pharmaceutical categories rather than a precision marker for fosamprenavir sodium procurement.

The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract to Chartwell Rx LLC for $2,999,999.11 over 12 months plus two optional renewal years under Invitation for Bid 26482DPHPREPDB53392 (awarded August 28, 2026), while Seminole County, Florida released an IFB for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to Sanford, Florida (response deadline July 26, 2023). Activity appears concentrated in the Southeast and Illinois, with both issuing bodies sourcing through cooperative purchasing or direct IFB processes. The mismatch between the code's stated commodity and the actual pharmaceutical products being procured—antibiotics, naloxone, and drug deactivation equipment rather than fosamprenavir—indicates this code may not be a reliable filter for businesses tracking genuine antiretroviral pharmaceutical opportunities at the state and local level.